DWT
AZN icon

Dorsey & Whitney Trust’s AstraZeneca AZN Stock Holding History

Dorsey & Whitney Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.28M Buy
11,570
+356
+3% +$68.6K 0.13% 158
2025
Q4 		$2.06M Sell
11,214
-5,752
-34% -$1.01M 0.11% 165
2025
Q3 		$2.6M Sell
16,966
-80
-0.5% -$12.1K 0.14% 138
2025
Q2 		$2.38M Sell
17,046
-555
-3% -$77.8K 0.13% 145
2025
Q1 		$2.59M Sell
17,601
-49
-0.3% -$7.09K 0.15% 134
2024
Q4 		$2.31M Buy
17,650
+94
+0.5% +$13.2K 0.13% 151
2024
Q3 		$2.74M Buy
17,556
+6,998
+66% +$1.13M 0.15% 131
2024
Q2 		$1.65M Buy
10,558
+193
+2% +$29K 0.11% 150
2024
Q1 		$1.4M Buy
10,365
+316
+3% +$41.8K 0.1% 178
2023
Q4 		$1.35M Buy
10,049
+121
+1% +$15.7K 0.1% 177
2023
Q3 		$1.34M Buy
9,928
+250
+3% +$34.1K 0.12% 158
2023
Q2 		$1.39M Buy
9,678
+660
+7% +$97.1K 0.11% 166
2023
Q1 		$1.25M Sell
9,018
-262
-3% -$35.3K 0.11% 170
2022
Q4 		$1.26M Buy
9,280
+906
+11% +$114K 0.12% 164
2022
Q3 		$918K Sell
8,374
-271
-3% -$34.4K 0.1% 191
2022
Q2 		$1.14M Buy
8,645
+900
+12% +$118K 0.12% 168
2022
Q1 		$1.03M Buy
7,745
+860
+12% +$103K 0.09% 196
2021
Q4 		$802K Buy
6,885
+540
+9% +$63.5K 0.07% 232
2021
Q3 		$763K Buy
6,345
+764
+14% +$88.9K 0.07% 224
2021
Q2 		$668K Buy
5,581
+237
+4% +$26K 0.06% 239
2021
Q1 		$532K Sell
5,344
-161
-3% -$16.2K 0.05% 269
2020
Q4 		$550K Sell
5,505
-85
-2% -$9K 0.06% 232
2020
Q3 		$612K Buy
5,590
+27
+0.5% +$3K 0.08% 204
2020
Q2 		$588K Buy
5,563
+341
+7% +$35.2K 0.08% 209
2020
Q1 		$466K Sell
5,222
-190
-4% -$17.9K 0.08% 210
2019
Q4 		$540K Hold
5,412
– – 0.07% 217
2019
Q3 		$482K Sell
5,412
-51
-0.9% -$4.42K 0.07% 223
2019
Q2 		$450K Buy
5,463
+649
+13% +$50.9K 0.07% 225
2019
Q1 		$389K Sell
4,814
-77
-2% -$6.07K 0.06% 240
2018
Q4 		$372K Buy
4,891
+167
+4% +$13K 0.07% 219
2018
Q3 		$374K Buy
4,724
+126
+3% +$9.53K 0.06% 232
2018
Q2 		$323K Buy
4,598
+239
+5% +$17.2K 0.06% 238
2018
Q1 		$305K Buy
4,359
+498
+13% +$34.5K 0.06% 239
2017
Q4 		$268K Sell
3,861
-1,748
-31% -$118K 0.05% 258
2017
Q3 		$380K Sell
5,609
-1,049
-16% -$66.3K 0.08% 187
2017
Q2 		$454K Buy
6,658
+47
+0.7% +$3.07K 0.09% 171
2017
Q1 		$411K Buy
+6,611
New +$385K 0.08% 179
2016
Q4 		– Sell
-3,374
Closed -$223K – 295
2016
Q3 		$223K Buy
+3,374
New +$221K 0.05% 246

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Dorsey & Whitney Trust's AZN Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its AstraZeneca (AZN) stake by 3.2% in Q1 2026, buying an estimated $68.6K and bringing the position to 11,570 shares worth $2.28M. The position accounts for 0.13% of the portfolio, ranked #158.

Dorsey & Whitney Trust first reported a position in AZN in Q3 2016 and has held it in 38 quarters since. The position peaked at $2.74M in Q3 2024. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Dorsey & Whitney Trust held 11,570 shares of AstraZeneca worth $2.28M as of Q1 2026.
  • Dorsey & Whitney Trust bought 356 AstraZeneca shares in Q1 2026, an estimated $68.6K.
  • AstraZeneca made up 0.13% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #158 holding.
  • Dorsey & Whitney Trust first reported a position in AstraZeneca in Q3 2016 and has held it in 38 quarters since.
  • Dorsey & Whitney Trust's AstraZeneca position peaked at $2.74M in Q3 2024.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.